Literature DB >> 9707379

A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders.

L L Judd1, H S Akiskal, J D Maser, P J Zeller, J Endicott, W Coryell, M P Paulus, J L Kunovac, A C Leon, T I Mueller, J A Rice, M B Keller.   

Abstract

BACKGROUND: Investigations of unipolar major depressive disorder (MDD) have focused primarily on major depressive episode remission/recovery and relapse/recurrence. This is the first prospective, naturalistic, long-term study of the weekly symptomatic course of MDD.
METHODS: The weekly depressive symptoms of 431 patients with MDD seeking treatment at 5 academic centers were divided into 4 levels of severity: (1) depressive symptoms at the threshold for MDD; (2) depressive symptoms at the threshold for minor depressive or dysthymic disorder (MinD); (3) subsyndromal or subthreshold depressive symptoms (SSDs), below the thresholds for MinD and MDD; and (4) no depressive symptoms. The percentage of weeks at each level, number of changes in symptom level, and medication status were analyzed overall and for 3 subgroups defined by mood disorder history.
RESULTS: Patients were symptomatically ill in 59% of weeks. Symptom levels changed frequently (1.8/y), and 9 of 10 patients spent weeks at 3 or 4 different levels during follow-up. The MinD (27%) and SSD (17%) symptom levels were more common than the MDD (15%) symptom level. Patients with double depression and recurrent depression had more chronic symptoms than patients with their first lifetime major depressive episode (72% and 65%, respectively, vs 46% of follow-up weeks).
CONCLUSION: The long-term weekly course of unipolar MDD is dominated by prolonged symptomatic chronicity. Combined MinD and SSD level symptoms were about 3 times more common (43%) than MDD level symptoms (15%). The symptomatic course is dynamic and changeable, and MDD, MinD, and SSD symptom levels commonly alternate over time in the same patients as a symptomatic continuum of illness activity of a single clinical disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707379     DOI: 10.1001/archpsyc.55.8.694

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  151 in total

1.  Should depression be managed as a chronic disease?

Authors:  G Andrews
Journal:  BMJ       Date:  2001-02-17

2.  Treating mood disorders.

Authors:  Russell T Joffe
Journal:  J Psychiatry Neurosci       Date:  2003-01       Impact factor: 6.186

3.  Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol.

Authors:  Charles L Raison; David B Rye; Bobbi J Woolwine; Gerald J Vogt; Breanne M Bautista; James R Spivey; Andrew H Miller
Journal:  Biol Psychiatry       Date:  2010-05-26       Impact factor: 13.382

4.  Double depression in an Australian population.

Authors:  Robert D Goldney; Laura J Fisher
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-11       Impact factor: 4.328

5.  Quality assessment of observational studies in psychiatry: an example  from perinatal psychiatric research.

Authors:  L E Ross; S Grigoriadis; L Mamisashvili; G Koren; M Steiner; C-L Dennis; A Cheung; P Mousmanis
Journal:  Int J Methods Psychiatr Res       Date:  2011-12       Impact factor: 4.035

6.  Temporal patterns of anxious and depressed mood in generalized anxiety disorder: a daily diary study.

Authors:  Lisa R Starr; Joanne Davila
Journal:  Behav Res Ther       Date:  2011-12-07

Review 7.  A tune in "a minor" can "b major": a review of epidemiology, illness course, and public health implications of subthreshold depression in older adults.

Authors:  Thomas W Meeks; Ipsit V Vahia; Helen Lavretsky; Ganesh Kulkarni; Dilip V Jeste
Journal:  J Affect Disord       Date:  2011-03       Impact factor: 4.839

8.  Love hurts (in more ways than one): specificity of psychological symptoms as predictors and consequences of romantic activity among early adolescent girls.

Authors:  Lisa R Starr; Joanne Davila; Catherine B Stroud; Po Ching Clara Li; Athena Yoneda; Rachel Hershenberg; Melissa Ramsay Miller
Journal:  J Clin Psychol       Date:  2012-02-03

9.  The impact of comorbid dysthymic disorder on outcome in personality disorders.

Authors:  David J Hellerstein; Andrew E Skodol; Eva Petkova; Hui Xie; John C Markowitz; Shirley Yen; John Gunderson; Carlos Grilo; Maria T Daversa; Thomas H McGlashan
Journal:  Compr Psychiatry       Date:  2010-01-08       Impact factor: 3.735

10.  Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders.

Authors:  Carlos M Grilo; Charles A Sanislow; John G Gunderson; Maria E Pagano; Shirley Yen; Mary C Zanarini; M Tracie Shea; Andrew E Skodol; Robert L Stout; Leslie C Morey; Thomas H McGlashan
Journal:  J Consult Clin Psychol       Date:  2004-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.